3D-bioprinted liver cancer models derived from primary hepatocytes for simulating cancer initiation and drug screening

In summary, we established both 2D and 3D models that replicate early HCC progression, offering valuable tools for drug screening and advancing our understanding of early carcinogenic mechanisms.